Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Blueprint Medicines Corp (BPMC)  
$108.05 1.35 (1.27%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 66,002,000
Market Cap: 7.13(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $43.96 - $108.78
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  486
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Blueprint Medicines is a precision therapy company that is inventing medicines for people with cancer and blood disorders. Co. is delivering ITS approved medicines, AYVAKIT®/AYVAKYT® (avapritinib) and GAVRETO® (pralsetinib), to patients in the U.S. and Europe, and Co. is globally developing various programs for systemic mastocytosis lung cancer and other genomically defined cancers, and cancer immunotherapy. Co.'s drug discovery approach combines its biological insights with its proprietary compound library and chemistry capabilities to design therapies, with the goal of delivering clinical benefit to patients based on the genetic driver of their disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,100
Total Buy Value $0 $0 $0 $48,378
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 135,368 195,596 253,676 391,848
Total Sell Value $12,372,551 $16,993,405 $19,890,743 $27,837,584
Total People Sold 12 12 12 12
Total Sell Transactions 21 29 37 63
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 570
  Page 8 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Beckman Daniella   –       •      –    2021-12-08 4/A A $0.00 $0 D/D 3,400 3,400     -
   Tango Therapeutics, Inc. Director   –       •      –    2021-12-08 4 A $0.00 $0 D/D 3,400 3,400     -
   Mccain Tracey L EVP and Chief Legal Officer   •       –      –    2021-12-07 4 AS $95.54 $486,490 D/D (5,000) 33,441 -30%     
   Mccain Tracey L EVP and Chief Legal Officer   •       –      –    2021-12-07 4 OE $28.36 $141,800 D/D 5,000 38,441     -
   Hurley Ariel Principal Accounting Officer   •       –      –    2021-11-16 4 AS $114.28 $222,846 D/D (1,950) 10,097 -44%     
   Hurley Ariel Principal Accounting Officer   •       –      –    2021-11-16 4 OE $1.87 $16,035 D/D 1,950 12,047     -
   Albers Jeffrey W. CEO and President   •       •      –    2021-11-15 4 AS $112.14 $3,435,099 D/D (30,000) 188,448 -42%     
   Albers Jeffrey W. CEO and President   •       •      –    2021-11-15 4 OE $1.87 $351,750 D/D 30,000 218,448     -
   Hewes L. Becker Chief Medical Officer   •       –      –    2021-11-15 4 AS $115.49 $84,192 D/D (729) 26,187 -42%     
   Hewes L. Becker Chief Medical Officer   •       –      –    2021-11-15 4 OE $66.24 $48,289 D/D 729 26,916     -
   Rossi Christina CHIEF COMMERCIAL OFFICER   •       –      –    2021-11-03 4 S $110.85 $56,644 D/D (511) 43,968 44%     
   Mccain Tracey L EVP and Chief Legal Officer   •       –      –    2021-11-03 4 AS $109.63 $552,812 D/D (5,000) 33,274 -44%     
   Mccain Tracey L EVP and Chief Legal Officer   •       –      –    2021-11-03 4 OE $28.36 $141,800 D/D 5,000 38,274     -
   Albers Jeffrey W. CEO and President   •       •      –    2021-11-01 4 AS $115.16 $575,800 D/D (5,000) 188,448 -48%     
   Albers Jeffrey W. CEO and President   •       •      –    2021-11-01 4 OE $15.01 $75,050 D/D 5,000 193,448     -
   Durso-Bumpus Debra Chief People Officer   •       –      –    2021-11-01 4 AS $111.47 $585,172 D/D (5,177) 30,874 -48%     
   Durso-Bumpus Debra Chief People Officer   •       –      –    2021-11-01 4 OE $18.00 $151,885 D/D 5,177 36,051     -
   Hewes L. Becker Chief Medical Officer   •       –      –    2021-10-15 4 AS $102.66 $74,839 D/D (729) 26,187 -40%     
   Hewes L. Becker Chief Medical Officer   •       –      –    2021-10-15 4 OE $66.24 $48,289 D/D 729 26,916     -
   Namouni Fouad President, R & D   •       –      –    2021-10-05 4 S $98.18 $318,201 D/D (3,241) 42,321 14%     
   Durso-Bumpus Debra Chief People Officer   •       –      –    2021-09-23 4 AS $110.01 $93,288 D/D (848) 30,874 -30%     
   Durso-Bumpus Debra Chief People Officer   •       –      –    2021-09-23 4 OE $36.05 $30,570 D/D 848 31,722     -
   Mccain Tracey L EVP and Chief Legal Officer   •       –      –    2021-09-23 4 AS $107.75 $2,721,349 D/D (25,000) 33,274 -30%     
   Mccain Tracey L EVP and Chief Legal Officer   •       –      –    2021-09-23 4 OE $28.36 $709,000 D/D 25,000 58,274     -
   Hurley Ariel Principal Accounting Officer   •       –      –    2021-09-23 4 AS $110.00 $66,000 D/D (600) 10,097 -30%     
  570 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us